RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Northpond Ventures
N

Northpond Ventures portfolio

Northpond Ventures has 3 portfolio companies on record at Recent Funding. Its most recent investment on record is Ori Biotech's $100M Series B+ round in January 2022, alongside Puhua Capital, Octopus Ventures, Novalis LifeSciences and 3 others. By category, its portfolio leans toward Health and bio (3) and Manufacturing and industrial (1). It has co-invested with Octopus Ventures, Amadeus Capital Partners and Chimera Investment.

Type: Investor.
Portfolio on Recent Funding: 3.
Deals, last 12 months: 0.
Capital in their rounds: $200M.
Latest deal: Ori Biotech · Jan 18, 2022.

What Northpond Ventures invests in

How Northpond Ventures invests

StageDealsCapital in rounds
Series B+ 2 100%$200M
YearDealsCapital in rounds
2021 1 50%$100M
2022 1 50%$100M

Share is of the 2 rounds on Recent Funding that name Northpond Ventures. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Northpond Ventures portfolio companies

CompanyRound with Northpond VenturesTotal raisedLatest raise
OOri Biotech
Health and bio
Series B+ · $100M$100MJan 18, 2022
Series B+
PPersonal Genome Diagnostics
Health and bio
Series B+ · $100M$123.8MNov 24, 2025
Series B+
OOutcomes4Me
Health and bio
backer$21MMay 29, 2025
round

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists Northpond Ventures, which is a subset of its real portfolio. API: /api/v1/investors/northpond-ventures (get a free API key). More: the most active VC firms and new venture capital funds.

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy